Literature DB >> 1178813

Chenodeoxycholic acid therapy for gallstones: effectiveness, toxicity and influence on bile acid metabolism.

O James, J Cullen, I A Bouchier.   

Abstract

Chenodeoxycholic acid (1 g daily) was administered to 10 patients with gallstones and three patients with biliary stricture and recurrent cholangitis. Four gallstone patients showed diminution or disappearance of stones including one patient whose stone was in the common bile duct. The patients with recurrent cholangitis showed marked improvement in symptoms during treatment. Serum bile acid levels were significantly elevated in 8 gallstone patients during treatment. Liver biopsy in eight gallstone patients during treatment revealed minor changes in five. Lithocholic acid and bile acid sulphates were found in only small amounts in the bile of patients during treatment. No significant trend in biliary lipid composition during treatment was observed. There was no overall trend in the group of patients whose stones disappeared or diminished. Changes in biliary bile acid composition and in bile acid pool sizes were variable following treatment and could not be correlated with the clinical results of treatment. A further trial of chenodeoxycholic acid is recommended in patients with stones in the biliary tree and recurrent cholangitis who are not amenable to surgical treatment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1178813

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  9 in total

1.  Choosing patients for chenodeoxycholic acid treatment.

Authors: 
Journal:  Br Med J       Date:  1977-04-30

2.  Effect of gallstone-dissolution therapy on human liver structure.

Authors:  M C Bateson; D Hopwood; I A Bouchier
Journal:  Am J Dig Dis       Date:  1977-04

3.  Lithocholate metabolism during chenotherapy for gallstone dissolution. 1. Serum levels of sulphated and unsulphated lithocholates.

Authors:  R N Allan; J L Thistle; A F Hofmann; J A Carter; P Y Yu
Journal:  Gut       Date:  1976-06       Impact factor: 23.059

4.  Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.

Authors:  T J Meredith; G V Williams; P N Maton; G M Murphy; H M Saxton; R H Dowling
Journal:  Gut       Date:  1982-05       Impact factor: 23.059

5.  Effect of varying doses of chenodeoxycholic acid on bile lipid and biliary bile acid composition in gallstone patients: a dose-response study.

Authors:  J L Thistle; A F Hofmann; P Y Yu; B Ott
Journal:  Am J Dig Dis       Date:  1977-01

6.  Effect of prolonged feeding with chenodeoxycholic acid on bile in patients with and without gallstones.

Authors:  M C Bateson; P E Ross; J Murison; I A Bouchier
Journal:  Gut       Date:  1977-08       Impact factor: 23.059

7.  Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients.

Authors:  E Roda; A Roda; C Sama; D Festi; G Mazzella; R Aldini; L Barbara
Journal:  Dig Dis Sci       Date:  1979-02       Impact factor: 3.199

Review 8.  Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

Authors:  J H Iser; A Sali
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

9.  Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet.

Authors:  D P Maudgal; R M Kupfer; T C Northfield
Journal:  Gut       Date:  1982-04       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.